S&P 500   3,845.43 (-0.64%)
DOW   31,451.45 (+0.19%)
QQQ   312.61 (-1.82%)
AAPL   123.52 (-1.28%)
MSFT   229.21 (-1.99%)
FB   256.89 (-0.81%)
GOOGL   2,021.35 (-2.09%)
TSLA   678.37 (-1.18%)
AMZN   3,030.01 (-2.08%)
NVDA   518.92 (-3.23%)
BABA   236.65 (+0.95%)
CGC   33.76 (-4.23%)
GE   13.59 (+4.70%)
MU   91.21 (+0.13%)
NIO   42.64 (-1.50%)
AMD   82.17 (-2.33%)
T   28.54 (+1.13%)
F   12.37 (-1.43%)
ACB   10.62 (-3.72%)
DIS   194.58 (+0.33%)
BA   233.99 (+4.86%)
NFLX   524.45 (-4.27%)
PFE   34.22 (+2.12%)
S&P 500   3,845.43 (-0.64%)
DOW   31,451.45 (+0.19%)
QQQ   312.61 (-1.82%)
AAPL   123.52 (-1.28%)
MSFT   229.21 (-1.99%)
FB   256.89 (-0.81%)
GOOGL   2,021.35 (-2.09%)
TSLA   678.37 (-1.18%)
AMZN   3,030.01 (-2.08%)
NVDA   518.92 (-3.23%)
BABA   236.65 (+0.95%)
CGC   33.76 (-4.23%)
GE   13.59 (+4.70%)
MU   91.21 (+0.13%)
NIO   42.64 (-1.50%)
AMD   82.17 (-2.33%)
T   28.54 (+1.13%)
F   12.37 (-1.43%)
ACB   10.62 (-3.72%)
DIS   194.58 (+0.33%)
BA   233.99 (+4.86%)
NFLX   524.45 (-4.27%)
PFE   34.22 (+2.12%)
S&P 500   3,845.43 (-0.64%)
DOW   31,451.45 (+0.19%)
QQQ   312.61 (-1.82%)
AAPL   123.52 (-1.28%)
MSFT   229.21 (-1.99%)
FB   256.89 (-0.81%)
GOOGL   2,021.35 (-2.09%)
TSLA   678.37 (-1.18%)
AMZN   3,030.01 (-2.08%)
NVDA   518.92 (-3.23%)
BABA   236.65 (+0.95%)
CGC   33.76 (-4.23%)
GE   13.59 (+4.70%)
MU   91.21 (+0.13%)
NIO   42.64 (-1.50%)
AMD   82.17 (-2.33%)
T   28.54 (+1.13%)
F   12.37 (-1.43%)
ACB   10.62 (-3.72%)
DIS   194.58 (+0.33%)
BA   233.99 (+4.86%)
NFLX   524.45 (-4.27%)
PFE   34.22 (+2.12%)
S&P 500   3,845.43 (-0.64%)
DOW   31,451.45 (+0.19%)
QQQ   312.61 (-1.82%)
AAPL   123.52 (-1.28%)
MSFT   229.21 (-1.99%)
FB   256.89 (-0.81%)
GOOGL   2,021.35 (-2.09%)
TSLA   678.37 (-1.18%)
AMZN   3,030.01 (-2.08%)
NVDA   518.92 (-3.23%)
BABA   236.65 (+0.95%)
CGC   33.76 (-4.23%)
GE   13.59 (+4.70%)
MU   91.21 (+0.13%)
NIO   42.64 (-1.50%)
AMD   82.17 (-2.33%)
T   28.54 (+1.13%)
F   12.37 (-1.43%)
ACB   10.62 (-3.72%)
DIS   194.58 (+0.33%)
BA   233.99 (+4.86%)
NFLX   524.45 (-4.27%)
PFE   34.22 (+2.12%)
Log in
OTCMKTS:VIAP

VIA Pharmaceuticals Stock Forecast, Price & News

$0.03
+0.01 (+49.50 %)
(As of 03/2/2021 12:48 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.01
MA: $0.02
$0.03
52-Week Range
$0.00
Now: $0.03
$0.04
Volume1,000 shs
Average Volume38,813 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.72
VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabetes. The company's drug development pipeline includes VIA-3196, a Phase-1 ready liver-directed thyroid hormone receptor (THR) beta agonist that targets dyslipidemia, such as high LDL cholesterol, high triglycerides, and elevated Lp(a); Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor, which is in pre-clinical development stage treatment of type 2 diabetes with upside potential in weight control and dyslipidemia; and VIA-2291, a 5-Lipoxygenase inhibitor that has completed third Phase 2 clinical trial for the treatment of atherosclerotic plaque, an underlying cause of heart attack, stroke, and other vascular diseases. VIA Pharmaceuticals, Inc. has two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. for THR beta agonist; and multiple compounds from preclinical DGAT1 metabolic disorders program. The company was founded in 2004 and is headquartered in San Francisco, California.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VIAP
CUSIPN/A
CIKN/A
Phone415-283-2200
Employees6
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1816th out of 1,968 stocks

Biological Products, Except Diagnostic Industry

173rd out of 177 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.03
+0.01 (+49.50 %)
(As of 03/2/2021 12:48 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VIAP News and Ratings via Email

Sign-up to receive the latest news and ratings for VIAP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











VIA Pharmaceuticals (OTCMKTS:VIAP) Frequently Asked Questions

What stocks does MarketBeat like better than VIA Pharmaceuticals?

Wall Street analysts have given VIA Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but VIA Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are VIA Pharmaceuticals' key executives?

VIA Pharmaceuticals' management team includes the following people:
  • Dr. Thomas Quertermous, Chief Scientific Officer & Member of Scientific Advisory Board (Age 69)

Who are some of VIA Pharmaceuticals' key competitors?

What is VIA Pharmaceuticals' stock symbol?

VIA Pharmaceuticals trades on the OTCMKTS under the ticker symbol "VIAP."

How do I buy shares of VIA Pharmaceuticals?

Shares of VIAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VIA Pharmaceuticals' stock price today?

One share of VIAP stock can currently be purchased for approximately $0.03.

How many employees does VIA Pharmaceuticals have?

VIA Pharmaceuticals employs 6 workers across the globe.

What is VIA Pharmaceuticals' official website?

The official website for VIA Pharmaceuticals is www.viapharmaceuticals.com.

Where are VIA Pharmaceuticals' headquarters?

VIA Pharmaceuticals is headquartered at 750 BATTERY STREET, SAN FRANCISCO CA, 94111.

How can I contact VIA Pharmaceuticals?

VIA Pharmaceuticals' mailing address is 750 BATTERY STREET, SAN FRANCISCO CA, 94111. The company can be reached via phone at 415-283-2200 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.